SciELO - Scientific Electronic Library Online

 
vol.32 número2Revisión de Creutzfeld-Jakob a propósito de dos casos clínicos en el Hospital Universitario San IgnacioPerfil de un adolescente con hiperplasia suprarrenal congénita índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Acta Neurológica Colombiana

versión impresa ISSN 0120-8748

Resumen

PALAZON CABANES, Begoña et al. Lipid emulsion as an antidote to progressive neurological impairment after injection of high doses of local anesthetic: case report. Acta Neurol Colomb. [online]. 2016, vol.32, n.2, pp.140-143. ISSN 0120-8748.

The infiltration of local anesthetic (LA) is increasingly widespread as an indication in the treatment of neuropathic pain. AL poisoning is rare but serious, life-threatening entity and its management may be very difficult. It occurs with decreased level of consciousness, seizures and cardiac conduction blocks. The lipid emulsion (EL) 20% is the only specific treatment described to date and it has improved the prognosis of these patients. We report the case of a patient with progressive neurological deterioration after injection of high doses of LA for treat a neuropathic pain refractory to other treatments. The patient was treated with lipid emulsion 20% with reversing all the neurological symptoms early and completely. The occurrence of progressive neurological symptoms in the context of a local anesthetic infiltration, should alert us to a possible poisoning and to start early treatment with lipid emulsion 20%, to avoid poor prognosis. However, prevention remains the main tool.

Palabras clave : Lipids; emulsion; toxic effects; local anesthetic; neuropathic pain.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons